BOZEMAN, Mont.--(BUSINESS WIRE)--Golden Helix, Inc. today announced that psychiatric researchers used HelixTree® Genetics Analysis Software to uncover evidence of a novel genetic locus that appears to increase the risk of developing schizophrenia. The study is the first successful whole genome association study for a psychiatric illness. Results of the study were published in the high-impact journal, Molecular Psychiatry.
